Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CD19 CAR-T cells with inducible caspase-9 safety switch

CAR-T cell therapy with iCasp9 safety switch
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD19 CAR-T cells with inducible caspase-9 safety switch, covering 2025-12-08 to 2025-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma [Phase 1]

See pricing